VEROPHARM PAO 
By PRESS-RELEASE
FOR IMMEDIATE DISTRIBUTION
APRIL 30, 2013 OJSC "VEROPHARM" announces operational performance indicators of the year 2012 Rx drugs
According to the results of the year 2012 total sales of the top five best selling Rx drugs amounted to RUR 1,369.2 million, which corresponds to 37.2% of sales in the Rx drugs segment and 24.9%[1] of the Company's total sales.
According to the results of the year 2012 the top five best selling Rx drugs are:
o Geptor (Ademetionine; ATC[2] «Digestive tract and metabolism»); sales increased by
47% as compared to the same period of previous year; 12.5% of sales in the Rx drugs
segment;
o Irunine (Itraconazole; ATC «Antimicrobials for systematic use»); sales in the segment made 7%;
o Cerepro (Choline Alfoscerate; ATC «Medications for the treatment of central nervous system deseases»); sales in the segment made 6.9%;
o Vero-epoetin (Epoetin beta, ATC «Antineoplastic and immunomodulating agents»);
sales in the segment made 5.7%;
o Amigrenin (Sumatriptan, ATC «Medications for the treatment of central nervous system deseases»); sales in the segment made 5.2%;
OTC drugs segment is characterized by the high degree of consolidation. It means that the top five best selling medicines make 98.7% of sales.
o Xilen (Xylometazoline; ATC «Medications for the treatment of respiratory system»); sales increased by 7.6% as compared to the same period of previous year; sales in the OTC drugs segment made 57.4%;
o Slabilen (Sodium picosulfate; ATC «Alimentary tract and metabolism»); sales increased by 1.2% as compared to the same period of previous year; sales in the OTC drugs segment made 24.6%;
o Motilak (Domperidone; ATC «Alimentary tract and metabolism»); sales in the OTC
drugs segment made 13.7%;
o Vitasharm and Vitatress (ATC «Vitamins»); sales in the OTC drugs segment made 2.0%;
107023, Moscow, Russia, Ochakovskoe shosse, 10-2-1, tel.: (+7495) 792 5330
o Ginecotex (Benzalkonium chloride; ATC «Medications for the treatment of urogenital organs»); sales in the OTC drugs segment made 0.9%.
Traditional drugs segment
According to the results of the year 2012 the top five best selling prescription medications are:
o Vero-Dexamethasone (Dexamethasone; ATC «Hormonal drugs for systematic use»);
sales in the traditional drugs segment made 39.2%;
o Pyridoxine (ATC «Alimentary tract and metabolism»); sales in the segment made
27.1%;
o Vero-Ciprofloxacin (Ciprofloxacin; ATC «Antimicrobials for systematic use»); sales in the segment made 11.1%;
o Flukonazole (Fluconazole; ATC «Antimicrobials for systematic use»); sales in the segment made 10.1%;
o Vero-Loperamide (Loperamide; ATC «Alimentary tract and metabolism»); sales in the segment made 7.8%.
According to the results of the year 2012 the top five best selling non-pharamaceutical products are:
o Conventional antimicrobial adhesive bandages; 37.0% of sales in the segment;
o Conventional reel adhesive bandages; 22.1% of sales in the segment; o Therapeutic patches - pepper plasters; 19.7% of sales in the segment; o Therapeutic patches - corn plasters; 18.8% of sales in the segment;
o Nutritional therapy (Comida); 1.6% of sales in the segment.
NEW DRUGS PRODUCTION AND SALESDuring 2012 Veropharm launched production and sales of the following new drugs and cosmetic products:
o Poludan (Polyadenilic acid + Polyuridilic acid; ATC «Medications for the sense organs
treatment»); new dosage - nasal drops 50 IU[3]/ml 5 ml
